Cargando…

Results of a prospective cardiovascular disease prevention program

The Cardiovascular Health Program (CHP) Registry is a 12-month, prospective study of therapeutic lifestyle change (TLC). Adult participants received comprehensive assessment of health behaviors and cardiovascular disease (CVD) risk factors. Personalized TLC action plans addressed modifiable health b...

Descripción completa

Detalles Bibliográficos
Autores principales: Eliasson, Arn, Kashani, Mariam, Vernalis, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020477/
https://www.ncbi.nlm.nih.gov/pubmed/33842199
http://dx.doi.org/10.1016/j.pmedr.2021.101344
_version_ 1783674590802739200
author Eliasson, Arn
Kashani, Mariam
Vernalis, Marina
author_facet Eliasson, Arn
Kashani, Mariam
Vernalis, Marina
author_sort Eliasson, Arn
collection PubMed
description The Cardiovascular Health Program (CHP) Registry is a 12-month, prospective study of therapeutic lifestyle change (TLC). Adult participants received comprehensive assessment of health behaviors and cardiovascular disease (CVD) risk factors. Personalized TLC action plans addressed modifiable health behaviors for diet, exercise, stress management, and sleep. Participants attended a half-day interactive workshop and met face-to-face with certified health coaches four times over 6 months. Monthly telephonic coaching for 6 more months completed the intervention. Measured outcomes included adherence to behavioral prescriptions, anthropometrics, CVD-relevant laboratory tests, and for a subset of participants, carotid intima-media thickness (CIMT). Of 965 participants, 648 (67%) completed the program and were included in the analysis. Participants were of mean age 55.4 ± 12.5 years, 57% women, and racially diverse. Adherence to prescribed TLC was substantial: dietary behaviors at goal rose from 53% to 86%, exercise 44% to 66%, perceived stress 65% to 79%, and sleep quality 28% to 49%. For participants with abnormal anthropometrics at baseline, there were improvements in body mass index in 63%, waist circumference (men 71%, women 74%), systolic BP 69%, and diastolic BP 71%. For participants with abnormal laboratory values at baseline, there were improvements in total cholesterol in 74%, LDL-cholesterol 65%, triglycerides 86%, fasting glucose 72%, and insulin resistance 71%. Improvements were not driven by prescribed medications. CIMT improved or showed no change in 70% of those measured, associated with significant improvements in sleep quality and longer total sleep time. Longer trials incorporating controls and major adverse CVD events are warranted.
format Online
Article
Text
id pubmed-8020477
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-80204772021-04-08 Results of a prospective cardiovascular disease prevention program Eliasson, Arn Kashani, Mariam Vernalis, Marina Prev Med Rep Regular Article The Cardiovascular Health Program (CHP) Registry is a 12-month, prospective study of therapeutic lifestyle change (TLC). Adult participants received comprehensive assessment of health behaviors and cardiovascular disease (CVD) risk factors. Personalized TLC action plans addressed modifiable health behaviors for diet, exercise, stress management, and sleep. Participants attended a half-day interactive workshop and met face-to-face with certified health coaches four times over 6 months. Monthly telephonic coaching for 6 more months completed the intervention. Measured outcomes included adherence to behavioral prescriptions, anthropometrics, CVD-relevant laboratory tests, and for a subset of participants, carotid intima-media thickness (CIMT). Of 965 participants, 648 (67%) completed the program and were included in the analysis. Participants were of mean age 55.4 ± 12.5 years, 57% women, and racially diverse. Adherence to prescribed TLC was substantial: dietary behaviors at goal rose from 53% to 86%, exercise 44% to 66%, perceived stress 65% to 79%, and sleep quality 28% to 49%. For participants with abnormal anthropometrics at baseline, there were improvements in body mass index in 63%, waist circumference (men 71%, women 74%), systolic BP 69%, and diastolic BP 71%. For participants with abnormal laboratory values at baseline, there were improvements in total cholesterol in 74%, LDL-cholesterol 65%, triglycerides 86%, fasting glucose 72%, and insulin resistance 71%. Improvements were not driven by prescribed medications. CIMT improved or showed no change in 70% of those measured, associated with significant improvements in sleep quality and longer total sleep time. Longer trials incorporating controls and major adverse CVD events are warranted. 2021-03-12 /pmc/articles/PMC8020477/ /pubmed/33842199 http://dx.doi.org/10.1016/j.pmedr.2021.101344 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Eliasson, Arn
Kashani, Mariam
Vernalis, Marina
Results of a prospective cardiovascular disease prevention program
title Results of a prospective cardiovascular disease prevention program
title_full Results of a prospective cardiovascular disease prevention program
title_fullStr Results of a prospective cardiovascular disease prevention program
title_full_unstemmed Results of a prospective cardiovascular disease prevention program
title_short Results of a prospective cardiovascular disease prevention program
title_sort results of a prospective cardiovascular disease prevention program
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020477/
https://www.ncbi.nlm.nih.gov/pubmed/33842199
http://dx.doi.org/10.1016/j.pmedr.2021.101344
work_keys_str_mv AT eliassonarn resultsofaprospectivecardiovasculardiseasepreventionprogram
AT kashanimariam resultsofaprospectivecardiovasculardiseasepreventionprogram
AT vernalismarina resultsofaprospectivecardiovasculardiseasepreventionprogram